NSIM
LFCR icon

North Star Investment Management’s Lifecore Biomedical LFCR Stock Holding History

North Star Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,725
Closed -$65K – 1033
2019
Q4 		$65K Hold
5,725
– – 0.01% 509
2019
Q3 		$62K Sell
5,725
-97,550
-94% -$1.06M 0.01% 511
2019
Q2 		$968K Sell
103,275
-43,900
-30% -$443K 0.11% 211
2019
Q1 		$1.81M Buy
147,175
+22,300
+18% +$272K 0.21% 134
2018
Q4 		$1.48M Sell
124,875
-11,000
-8% -$151K 0.19% 138
2018
Q3 		$1.96M Hold
135,875
– – 0.22% 128
2018
Q2 		$2.02M Sell
135,875
-40,000
-23% -$556K 0.23% 120
2018
Q1 		$2.29M Sell
175,875
-22,000
-11% -$289K 0.27% 101
2017
Q4 		$2.49M Sell
197,875
-300
-0.2% -$3.79K 0.3% 93
2017
Q3 		$2.57M Buy
198,175
+30,775
+18% +$406K 0.33% 87
2017
Q2 		$2.49M Hold
167,400
– – 0.33% 82
2017
Q1 		$2.01M Buy
167,400
+17,000
+11% +$215K 0.28% 99
2016
Q4 		$2.08M Sell
150,400
-22,125
-13% -$307K 0.31% 89
2016
Q3 		$2.31M Hold
172,525
– – 0.41% 73
2016
Q2 		$1.86M Hold
172,525
– – 0.34% 86
2016
Q1 		$1.81M Sell
172,525
-1,575
-0.9% -$17.3K 0.35% 81
2015
Q4 		$2.06M Sell
174,100
-3,550
-2% -$43.6K 0.4% 71
2015
Q3 		$2.07M Hold
177,650
– – 0.43% 64
2015
Q2 		$2.56M Hold
177,650
– – 0.47% 57
2015
Q1 		$2.48M Sell
177,650
-16,624
-9% -$230K 0.46% 60
2014
Q4 		$2.68M Buy
194,274
+11,524
+6% +$149K 0.51% 52
2014
Q3 		$2.24M Buy
182,750
+27,125
+17% +$339K 0.45% 61
2014
Q2 		$1.94M Buy
155,625
+5,000
+3% +$58.8K 0.39% 69
2014
Q1 		$1.68M Buy
150,625
+100,900
+203% +$1.11M 0.35% 80
2013
Q4 		$603K Buy
49,725
+250
+0.5% +$2.98K 0.13% 185
2013
Q3 		$604K Buy
+49,475
New +$690K 0.16% 159

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

North Star Investment Management's LFCR Position: Q1 2020 in Review

North Star Investment Management sold out of Lifecore Biomedical (LFCR) in Q1 2020, closing a stake of 5,725 shares — an estimated $65K sold.

North Star Investment Management first reported a position in LFCR in Q3 2013 and held it in 26 quarters. The position peaked at $2.68M in Q4 2014. 88 funds tracked by Wall St. Rank hold LFCR as of Q1 2020.

  • North Star Investment Management reported no remaining Lifecore Biomedical position as of Q1 2020 after selling out during the quarter.
  • North Star Investment Management sold 5,725 Lifecore Biomedical shares in Q1 2020, an estimated $65K.
  • North Star Investment Management first reported a position in Lifecore Biomedical in Q3 2013 and held it in 26 quarters.
  • North Star Investment Management's Lifecore Biomedical position peaked at $2.68M in Q4 2014.
  • 88 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2020.

Based on North Star Investment Management's 13F filing for Q1 2020, filed 23 Apr 2020.